Načítá se...
ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice
Obesity is one of the most prevalent metabolic diseases in the Western world and correlates directly with insulin resistance, which may ultimately culminate in type 2 diabetes (T2D). We sought to ascertain whether the human metalloproteinase A Disintegrin and Metalloproteinase 19 (ADAM19) correlates...
Uloženo v:
| Vydáno v: | Mediators Inflamm |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi Publishing Corporation
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5318628/ https://ncbi.nlm.nih.gov/pubmed/28265178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7281986 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|